The flower industry gets the genetic engineering blues.

Area of Science:

• Agricultural Science
• Biotechnology
• Plant Science

Background:

• Genetically engineered (GE) crops have achieved significant success, with over 2.1 billion hectares cultivated globally.
• Current GE cultivation predominantly features large-scale commodity crops like corn and soybean, neglecting specialty crops.
• Genetically engineered flowers represent a significantly underrepresented area in agricultural biotechnology.

Purpose of the Study:

• To highlight the underrepresentation of genetically engineered flowers in commercial cultivation.
• To identify the barriers hindering the development and commercialization of GE flowers.
• To advocate for a revised regulatory framework to foster innovation in GE ornamental plants.

Main Methods:

• Review of global GE crop cultivation data.
• Analysis of research trends in GE flower development.
• Assessment of regulatory impacts on specialty crop commercialization.

Main Results:

• Despite research in GE flowers (carnation, rose, chrysanthemum, petunia), commercialization remains limited.
• The high cost and regulatory uncertainty associated with government approval are major impediments.
• Significant economic opportunities exist in the GE flower market, currently unrealized.

Conclusions:

• The commercialization of genetically engineered flowers is hindered by regulatory challenges.
• A scientifically defensible and risk-based regulatory climate is essential for unlocking the potential of GE flowers.
• Policy reform is critical to stimulate development and investment in this neglected sector.